Fundraising FoxRegor
Shanghai, CN · 4 known investors
Find your way into Regor
Sign up to find every way you can get introduced to Regor
- Your email: who you already know at Regor, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Regor team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Regor is a drug discovery company that uses a computational platform (rCARD) to identify and optimize preclinical small-molecule candidates in metabolism, oncology, and immunology, which it licenses to pharmaceutical companies for clinical development. Its pipeline includes RGT-075, an oral GLP-1R agonist for obesity and type 2 diabetes, and next-generation CDK inhibitors for breast cancer.
Founders & leadership
Investors · 4
How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does Regor do?
- Regor is a drug discovery company that uses a computational platform (rCARD) to identify and optimize preclinical small-molecule candidates in metabolism, oncology, and immunology, which it licenses to pharmaceutical companies for clinical development. Its pipeline includes RGT-075, an oral GLP-1R agonist for obesity and type 2 diabetes, and next-generation CDK inhibitors for breast cancer.
- Who founded Regor?
- Regor was founded by Xiayang Qiu.
- Who are Regor's investors?
- Regor's investors include LAV, Lilly Asia Ventures, Vertex Ventures, Vertex Ventures China.
- Where is Regor headquartered?
- Regor is headquartered in Shanghai, CN.